Clinical Trial Update: Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of zoledronic acid (Zometa) with cyclophosphamide in patients with neuroblastoma and cortical bone involvement; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Zometa (Zoledronic acid)

Snippet

Sponsor: Baylor College of Medicine | Conditions: NEUROBLASTOMA | Phase 1 | Status: COMPLETED